NCT00005860 Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum Status COMPLETED Phase PHASE1
NCT00005815 Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00005814 Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00005806 Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005805 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Status COMPLETED Phase PHASE3
NCT00005791 Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00005638 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00005637 Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005636 Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery Status COMPLETED Phase PHASE3
NCT00005634 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Status COMPLETED Phase PHASE1
NCT00005633 Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT00005632 Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT00005631 Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00005630 Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005628 Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00005625 Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma Status COMPLETED Phase PHASE2
NCT00005618 Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE2
NCT00005616 Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00005599 Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer Status COMPLETED Phase PHASE2
NCT00005070 Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2